Trademark: 87757230
Word
POWERED BY BIOHM
Status
Registered
Status Code
700
Status Date
Tuesday, April 19, 2022
Serial Number
87757230
Registration Number
6707595
Registration Date
Tuesday, April 19, 2022
Mark Type
4000
Filing Date
Tuesday, January 16, 2018
Published for Opposition
Tuesday, December 25, 2018

Trademark Owner History
BIOHM HEALTH INC. -
BIOHM HEALTH LLC - Original Registrant
PathoBiome LLC - Owner At Publication

Classifications
5 Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; beverages containing probiotic compositions for use as a nutritional supplement; food supplements containing probiotic compositions; human food supplements products containing probiotic compositions; animal food products containing probiotic compositions, namely, probiotic animal feed; dietary supplement drink mixes, namely, probiotic compositions in the form of mixes to added to beverages; dietary supplements in the nature of probiotic compositions for mixing with cereal
1 Food products containing probiotic compositions, namely, probiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; human food products containing probiotic compositions, namely, probiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; animal food products containing probiotic compositions, namely, nutritional additives for use in manufacturing animal feed

Trademark Events
Feb 15, 2023
Automatic Update Of Assignment Of Ownership
Apr 19, 2022
Registered-Principal Register
Mar 15, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 13, 2022
Allowed Principal Register - Sou Accepted
Mar 1, 2022
Statement Of Use Processing Complete
Feb 18, 2022
Use Amendment Filed
Feb 18, 2022
Teas Statement Of Use Received
Aug 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2021
Sou Extension 5 Granted
Jul 28, 2021
Sou Extension 5 Filed
Aug 6, 2021
Case Assigned To Intent To Use Paralegal
Jul 28, 2021
Teas Extension Received
Feb 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 15, 2021
Sou Extension 4 Granted
Feb 15, 2021
Sou Extension 4 Filed
Feb 15, 2021
Teas Extension Received
Oct 5, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 5, 2020
Teas Change Of Correspondence Received
Oct 5, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 5, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 5, 2020
Teas Change Of Owner Address Received
Aug 21, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 19, 2020
Sou Extension 3 Granted
Aug 19, 2020
Sou Extension 3 Filed
Aug 19, 2020
Teas Extension Received
Feb 28, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 27, 2020
Sou Extension 2 Granted
Feb 18, 2020
Sou Extension 2 Filed
Feb 27, 2020
Case Assigned To Intent To Use Paralegal
Feb 18, 2020
Teas Extension Received
Feb 18, 2020
Teas Change Of Correspondence Received
Aug 20, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2019
Sou Extension 1 Granted
Aug 16, 2019
Sou Extension 1 Filed
Aug 16, 2019
Teas Extension Received
Feb 19, 2019
Noa E-Mailed - Sou Required From Applicant
Jan 30, 2019
Automatic Update Of Assignment Of Ownership
Dec 25, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 25, 2018
Published For Opposition
Dec 5, 2018
Notification Of Notice Of Publication E-Mailed
Nov 12, 2018
Assigned To Lie
Oct 28, 2018
Approved For Pub - Principal Register
Oct 26, 2018
Teas/Email Correspondence Entered
Oct 26, 2018
Correspondence Received In Law Office
Oct 26, 2018
Teas Response To Office Action Received
Apr 30, 2018
Notification Of Non-Final Action E-Mailed
Apr 30, 2018
Non-Final Action E-Mailed
Apr 30, 2018
Non-Final Action Written
Apr 26, 2018
Assigned To Examiner
Jan 29, 2018
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24